These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1301405)

  • 1. The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction.
    Williamson JR; Arrigoni-Martelli E
    Int J Clin Pharmacol Res; 1992; 12(5-6):247-52. PubMed ID: 1301405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The hormone-metabolic changes in the diabetic angiopathy].
    Tat'ianenko LV; Shaposhnikova GI; Gulevskaia TS; Smirnov LD
    Vopr Med Khim; 1998; 44(1):55-62. PubMed ID: 9575613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta.
    Irat AM; Aktan F; Ozansoy G
    J Pharm Pharmacol; 2003 Oct; 55(10):1389-95. PubMed ID: 14607021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of reactive oxygen species in diabetes-induced endothelial dysfunction.
    Zúrová-Nedelcevová J; Navarová J; Drábiková K; Jancinová V; Petríková M; Bernátová I; Kristová V; Snirc V; Nosál'ová V; Sotníková R
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():168-71. PubMed ID: 17159807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
    Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
    Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nicotinamide coenzyme regulation of the sorbitol pathway of glucose metabolism in the aorta of rats with streptozotocin diabetes].
    Obrosova IG; Velikiĭ NN; Efimov AS
    Vopr Med Khim; 1985; 31(2):125-8. PubMed ID: 3159151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects.
    Eckel RH; Hanson AS; Chen AY; Berman JN; Yost TJ; Brass EP
    Diabetes; 1992 May; 41(5):641-7. PubMed ID: 1568535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1.
    Marfella R; D'Amico M; Di Filippo C; Piegari E; Nappo F; Esposito K; Berrino L; Rossi F; Giugliano D
    Diabetologia; 2002 Aug; 45(8):1172-81. PubMed ID: 12189448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic energy metabolism in diabetes: therapeutic implications.
    Pogatsa G
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S29-33. PubMed ID: 11286305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.
    Tilton RG
    Microsc Res Tech; 2002 Jun; 57(5):390-407. PubMed ID: 12112445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Will the theory of metabolic memory change our therapeutic strategies in the face of type 2 diabetes?].
    Ruiz J; Egli M
    Rev Med Suisse; 2005 Jun; 1(22):1485-6, 1488-90. PubMed ID: 16025887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
    Virmani A; Gaetani F; Binienda Z
    Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of exercise training on cardiac long-chain acylcarnitine levels in diabetic rats.
    Broderick TL; St-Laurent R; Rousseau-Migneron S; Tancrede G; Nadeau A
    Diabetes Res; 1990 Jun; 14(2):83-6. PubMed ID: 2134218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral magnesium administration prevents vascular complications in STZ-diabetic rats.
    Soltani N; Keshavarz M; Sohanaki H; Dehpour AR; Zahedi Asl S
    Life Sci; 2005 Feb; 76(13):1455-64. PubMed ID: 15680310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
    J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrotyrosine: new findings as a marker of postprandial oxidative stress.
    Ceriello A
    Int J Clin Pract Suppl; 2002 Jul; (129):51-8. PubMed ID: 12166608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
    Guillausseau PJ
    Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism.
    Hoffmann A; Gloe T; Pohl U
    J Cell Physiol; 2001 Jul; 188(1):33-44. PubMed ID: 11382920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.